Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Advaxis Stock Price (Quote) NASDAQ:ADXS
$0.0680 ( 4.78% ) Friday, 20th May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.0550 | $0.10 | Friday, 20th May 2022 ADXS stock ended at $0.0680. This is 4.78% more than the trading day before Thursday, 19th May 2022. During the day the stock fluctuated 24.92% from a day low at $0.0600 to a day high of $0.0750. |
| 90 days | $0.0550 | $0.14 | |
| 52 weeks | $0.0550 | $0.71 |
Historical Advaxis prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-20 | $0.0600 | $0.0750 | $0.0600 | $0.0680 | 909 884 |
| 2022-05-19 | $0.0655 | $0.0670 | $0.0581 | $0.0649 | 472 892 |
| 2022-05-18 | $0.0680 | $0.0749 | $0.0652 | $0.0749 | 353 719 |
| 2022-05-17 | $0.0605 | $0.0700 | $0.0605 | $0.0680 | 858 146 |
| 2022-05-16 | $0.0640 | $0.0700 | $0.0610 | $0.0666 | 244 701 |
| 2022-05-13 | $0.0700 | $0.0700 | $0.0580 | $0.0640 | 435 901 |
| 2022-05-12 | $0.0600 | $0.0700 | $0.0550 | $0.0700 | 369 710 |
| 2022-05-11 | $0.0670 | $0.0694 | $0.0600 | $0.0650 | 366 961 |
| 2022-05-10 | $0.0699 | $0.0699 | $0.0699 | $0.0699 | 0 |
| 2022-05-09 | $0.0760 | $0.0825 | $0.0633 | $0.0699 | 604 189 |
| 2022-05-06 | $0.0800 | $0.0900 | $0.0796 | $0.0815 | 157 379 |
| 2022-05-05 | $0.0900 | $0.0900 | $0.0814 | $0.0830 | 387 536 |
| 2022-05-04 | $0.0901 | $0.0901 | $0.0801 | $0.0900 | 236 722 |
| 2022-05-03 | $0.0800 | $0.0900 | $0.0800 | $0.0804 | 1 573 361 |
| 2022-05-02 | $0.0785 | $0.0900 | $0.0720 | $0.0890 | 790 952 |
| 2022-04-29 | $0.0810 | $0.0873 | $0.0785 | $0.0840 | 82 370 |
| 2022-04-28 | $0.0820 | $0.0850 | $0.0781 | $0.0810 | 183 287 |
| 2022-04-27 | $0.0880 | $0.0880 | $0.0781 | $0.0820 | 215 783 |
| 2022-04-26 | $0.0850 | $0.10 | $0.0811 | $0.0880 | 642 752 |
| 2022-04-25 | $0.0853 | $0.10 | $0.0780 | $0.0900 | 693 458 |
| 2022-04-22 | $0.0850 | $0.0900 | $0.0780 | $0.0830 | 234 800 |
| 2022-04-21 | $0.0900 | $0.0900 | $0.0800 | $0.0850 | 239 300 |
| 2022-04-20 | $0.0900 | $0.0900 | $0.0810 | $0.0880 | 588 400 |
| 2022-04-19 | $0.0870 | $0.0900 | $0.0750 | $0.0900 | 437 600 |
| 2022-04-18 | $0.0870 | $0.0900 | $0.0750 | $0.0790 | 746 000 |
| 2022-04-14 | $0.0920 | $0.0950 | $0.0828 | $0.0885 | 257 209 |
| 2022-04-13 | $0.11 | $0.11 | $0.0900 | $0.0920 | 465 269 |
| 2022-04-12 | $0.0900 | $0.11 | $0.0850 | $0.0998 | 298 552 |
| 2022-04-11 | $0.0983 | $0.11 | $0.0900 | $0.0940 | 154 275 |
| 2022-04-08 | $0.10 | $0.12 | $0.10 | $0.10 | 244 000 |
| 2022-04-07 | $0.11 | $0.12 | $0.10 | $0.10 | 125 400 |
| 2022-04-06 | $0.11 | $0.12 | $0.10 | $0.11 | 373 000 |
| 2022-04-05 | $0.11 | $0.11 | $0.0900 | $0.11 | 309 200 |
| 2022-04-04 | $0.11 | $0.13 | $0.11 | $0.11 | 311 200 |
| 2022-04-01 | $0.12 | $0.12 | $0.11 | $0.12 | 193 573 |
| 2022-03-31 | $0.12 | $0.12 | $0.11 | $0.12 | 608 738 |
| 2022-03-30 | $0.12 | $0.13 | $0.12 | $0.12 | 137 040 |
| 2022-03-29 | $0.12 | $0.13 | $0.11 | $0.12 | 149 200 |
| 2022-03-28 | $0.12 | $0.13 | $0.12 | $0.12 | 434 500 |
| 2022-03-25 | $0.13 | $0.13 | $0.12 | $0.12 | 352 000 |
| 2022-03-24 | $0.12 | $0.13 | $0.12 | $0.12 | 234 600 |
| 2022-03-23 | $0.12 | $0.13 | $0.11 | $0.12 | 358 000 |
| 2022-03-22 | $0.13 | $0.13 | $0.12 | $0.12 | 196 142 |
| 2022-03-21 | $0.12 | $0.13 | $0.12 | $0.13 | 260 710 |
| 2022-03-18 | $0.12 | $0.14 | $0.12 | $0.13 | 283 416 |
| 2022-03-17 | $0.12 | $0.14 | $0.12 | $0.13 | 490 700 |
| 2022-03-16 | $0.12 | $0.13 | $0.11 | $0.12 | 383 000 |
| 2022-03-15 | $0.14 | $0.14 | $0.11 | $0.12 | 308 700 |
| 2022-03-14 | $0.11 | $0.14 | $0.11 | $0.12 | 2 082 400 |
| 2022-03-11 | $0.12 | $0.12 | $0.10 | $0.12 | 329 500 |
Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. Its lead product Axalimogene filolisbac (ADXS-HPV), an Lm-LLO immunotherapy product candidate, which completed its Phase II study used for the treatment of human papilloma virus (HPV) associated cancers, including cervical, head and neck, and anal cancer. The company is also dev... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
